Zymeworks Inc. (NYSE: ZYME) Files An 8-K Entry into a Material Definitive AgreementItem 1.01
Zymeworks Inc. ExhibitEX-99.1 2 d596335dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Zymeworks and BeiGene Announce License and Collaboration Agreement for Zymeworks’ HER2-Targeted Therapeutic Candidates,…To view the full exhibit click here
